# FAM124A

## Overview
FAM124A is a gene that encodes a protein belonging to the family with sequence similarity 124 member A. This protein is primarily involved in transcriptional regulation and chromatin remodeling, processes essential for modulating gene expression within the nucleus. The FAM124A protein plays a critical role in maintaining cellular homeostasis and proper organismal development by ensuring that genes are expressed at appropriate levels and times. Its involvement in chromatin remodeling suggests a dynamic role in genome regulation, allowing cells to adapt to various signals and environmental changes. While the precise mechanisms of FAM124A's function are still under investigation, its importance in cellular biology is underscored by its regulatory capabilities. Additionally, alterations in FAM124A expression have been associated with several diseases, indicating its potential clinical significance (Malla2021A; Wang2017Transcriptome; Lee2023Concentration).

## Function
FAM124A is a gene that encodes a protein involved in various cellular processes, primarily associated with transcriptional regulation and chromatin remodeling. The protein encoded by FAM124A is typically localized in the nucleus, where it plays a significant role in influencing gene expression. This nuclear localization is crucial for its function in modulating the accessibility of chromatin, thereby impacting the transcriptional activity of specific genes. By participating in these processes, FAM124A contributes to the maintenance of normal cellular functions and is essential for proper organismal development. The activity of the FAM124A protein ensures that genes are expressed at the right time and in the correct amounts, which is vital for cellular homeostasis and the prevention of developmental abnormalities. Its role in chromatin remodeling suggests that it may be involved in the dynamic regulation of the genome, allowing cells to respond to various signals and environmental changes effectively. The precise mechanisms by which FAM124A influences these processes are still under investigation, but its involvement in transcriptional regulation underscores its importance in cellular biology.

## Clinical Significance
FAM124A has been implicated in several conditions through alterations in its expression levels. In the context of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), FAM124A shows decreased protein expression in affected tissues compared to controls. This suggests a disease-dependent pattern of expression, although the study does not directly link FAM124A to specific disease mechanisms beyond this observation (Lee2023Concentration).

In severe mycoplasma pneumoniae pneumonia (MPP), FAM124A is upregulated in severe cases compared to mild ones. This differential expression indicates a potential role in the immune response and inflammation associated with severe MPP, although the specific contributions of FAM124A remain unclear (Wang2017Transcriptome).

FAM124A is also upregulated in blood monocytes from patients with Huntington's disease (HD), a neurodegenerative disorder. This change in expression suggests a possible involvement in the disease's pathology, although the exact role of FAM124A in HD is not fully understood (Malla2021A). These findings highlight the gene's potential involvement in various disease processes, warranting further investigation into its clinical significance.

## Interactions



## References


[1. (Wang2017Transcriptome) Kuo Wang, Man Gao, Mingyue Yang, Fanzheng Meng, Deli Li, Ruihua Lu, Yan Wang, Huadong Zhuang, Mengyao Li, Genhong Cheng, and Xiaosong Wang. Transcriptome analysis of bronchoalveolar lavage fluid from children with severe mycoplasma pneumoniae pneumonia reveals novel gene expression and immunodeficiency. Human Genomics, March 2017. URL: http://dx.doi.org/10.1186/s40246-017-0101-y, doi:10.1186/s40246-017-0101-y. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40246-017-0101-y)

[2. (Malla2021A) Bimala Malla, Xuanzong Guo, Gökçe Senger, Zoi Chasapopoulou, and Ferah Yildirim. A systematic review of transcriptional dysregulation in huntington’s disease studied by rna sequencing. Frontiers in Genetics, October 2021. URL: http://dx.doi.org/10.3389/fgene.2021.751033, doi:10.3389/fgene.2021.751033. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2021.751033)

[3. (Lee2023Concentration) Soo Jung Lee, Akhil Kondepudi, Kelly Z. Young, Xiaojie Zhang, Naw May Pearl Cartee, Jijun Chen, Krystal Yujin Jang, Gang Xu, Jimo Borjigin, and Michael M. Wang. Concentration of non-myocyte proteins in arterial media of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. PLOS ONE, 18(2):e0281094, February 2023. URL: http://dx.doi.org/10.1371/journal.pone.0281094, doi:10.1371/journal.pone.0281094. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0281094)